The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements which has been first introduced by Jennifer Doudna. Here is the review of the CRISPR system principal and applications.
Genome engineering uses programmable nucleases like CRISPR-Cas9 to make targeted modifications to DNA. CRISPR-Cas9 is an adaptive immune system in bacteria that uses Cas9, an RNA-guided DNA endonuclease, to cleave DNA when guided by CRISPR RNA (crRNA). The Cas9 protein uses crRNA and trans-activating CRISPR RNA (tracrRNA) to induce double-strand breaks in DNA matching the crRNA sequence. CRISPR-Cas9 allows for efficient, precise genome editing and has applications in gene therapy, agriculture, and research.
This document provides an overview of genome engineering techniques from older methods to newer CRISPR/Cas9 technology. It discusses how genes can be transferred between organisms using vectors like plasmids or viruses. Older techniques like ZFN and TALEN cut DNA at specific sites, while CRISPR/Cas9 uses a Cas9 enzyme guided by CRISPR RNA to make precise cuts. Delivery methods for Cas9 include plasmids, mRNA, and RNP complexes. Viral vectors like AAV are commonly used but have limits. Physical methods also deliver Cas9 via nanoparticles or peptides.
This document discusses using the CRISPR-Cas9 system to engineer plant genomes for disease resistance. It describes how CRISPR-Cas9 uses RNA-guided nucleases to introduce targeted double-strand breaks, which can then be repaired through non-homologous end joining or homology-directed repair. This allows for knocking out or editing genes. The document outlines different components of the CRISPR-Cas9 system and various methods for delivering it to plant cells and tissues to modify plant genomes.
The document provides an introduction to the CRISPR/Cas9 genome editing technique. It discusses that CRISPR/Cas9 uses guide RNAs to direct the Cas9 nuclease to cut DNA at specific locations, and this double strand break can be repaired through nonhomologous end joining or homology directed repair to knock out or knock in genes. It also explains that CRISPR/Cas9 is more efficient, less expensive, and easier to use than previous genome editing techniques like ZFNs and TALENs. The document outlines several applications of CRISPR/Cas9 in biomedical research areas such as immunology, stem cell research, and generating transgenic animals.
CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that have previously infected the prokaryote and are used to detect and destroy DNA from similar phages during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.
Cas9 (CRISPR-associated protein 9) is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within organisms.This editing process has a wide variety of applications including basic biological research, development of biotechnology products, and treatment of diseases.
The CRISPR-Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages that provides a form of acquired immunity. RNA harboring the spacer sequence helps Cas (CRISPR-associated) proteins recognize and cut foreign pathogenic DNA. Other RNA-guided Cas proteins cut foreign RNA. CRISPR are found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.
Genome editing with the CRISPR-Cas9 system has become one of the major tools in modern biotechnology. This slide share discusses the fundamentals in a simple, easy to understand format.
The Efficiency and Ethics of the CRISPR System in Human EmbryosStephen Cranwell
This document summarizes research on the CRISPR/Cas9 system for genome editing in human embryos. It discusses efforts to understand DNA repair mechanisms after inducing double-strand breaks, reduce off-target mutations, and improve the specificity and efficiency of editing. While the technology shows promise, significant issues around off-target effects, mosaicism, and ethical concerns must still be addressed before any clinical applications. The document concludes that further basic research is needed to advance the field while also having open discussions on societal implications.
Introduction to CRISPR Cas9 technology. View in slide show after downloading for better viewing. Description is minimal, but it will be worth going through the slides that are full of pictures, if you have a minimal understanding of CRISPR.
Prepared in Oct 2015
Genome engineering uses programmable nucleases like CRISPR-Cas9 to make targeted modifications to DNA. CRISPR-Cas9 is an adaptive immune system in bacteria that uses Cas9, an RNA-guided DNA endonuclease, to cleave DNA when guided by CRISPR RNA (crRNA). The Cas9 protein uses crRNA and trans-activating CRISPR RNA (tracrRNA) to induce double-strand breaks in DNA matching the crRNA sequence. CRISPR-Cas9 allows for efficient, precise genome editing and has applications in gene therapy, agriculture, and research.
This document provides an overview of genome engineering techniques from older methods to newer CRISPR/Cas9 technology. It discusses how genes can be transferred between organisms using vectors like plasmids or viruses. Older techniques like ZFN and TALEN cut DNA at specific sites, while CRISPR/Cas9 uses a Cas9 enzyme guided by CRISPR RNA to make precise cuts. Delivery methods for Cas9 include plasmids, mRNA, and RNP complexes. Viral vectors like AAV are commonly used but have limits. Physical methods also deliver Cas9 via nanoparticles or peptides.
This document discusses using the CRISPR-Cas9 system to engineer plant genomes for disease resistance. It describes how CRISPR-Cas9 uses RNA-guided nucleases to introduce targeted double-strand breaks, which can then be repaired through non-homologous end joining or homology-directed repair. This allows for knocking out or editing genes. The document outlines different components of the CRISPR-Cas9 system and various methods for delivering it to plant cells and tissues to modify plant genomes.
The document provides an introduction to the CRISPR/Cas9 genome editing technique. It discusses that CRISPR/Cas9 uses guide RNAs to direct the Cas9 nuclease to cut DNA at specific locations, and this double strand break can be repaired through nonhomologous end joining or homology directed repair to knock out or knock in genes. It also explains that CRISPR/Cas9 is more efficient, less expensive, and easier to use than previous genome editing techniques like ZFNs and TALENs. The document outlines several applications of CRISPR/Cas9 in biomedical research areas such as immunology, stem cell research, and generating transgenic animals.
CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that have previously infected the prokaryote and are used to detect and destroy DNA from similar phages during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.
Cas9 (CRISPR-associated protein 9) is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR-Cas9 that can be used to edit genes within organisms.This editing process has a wide variety of applications including basic biological research, development of biotechnology products, and treatment of diseases.
The CRISPR-Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages that provides a form of acquired immunity. RNA harboring the spacer sequence helps Cas (CRISPR-associated) proteins recognize and cut foreign pathogenic DNA. Other RNA-guided Cas proteins cut foreign RNA. CRISPR are found in approximately 50% of sequenced bacterial genomes and nearly 90% of sequenced archaea.
Genome editing with the CRISPR-Cas9 system has become one of the major tools in modern biotechnology. This slide share discusses the fundamentals in a simple, easy to understand format.
The Efficiency and Ethics of the CRISPR System in Human EmbryosStephen Cranwell
This document summarizes research on the CRISPR/Cas9 system for genome editing in human embryos. It discusses efforts to understand DNA repair mechanisms after inducing double-strand breaks, reduce off-target mutations, and improve the specificity and efficiency of editing. While the technology shows promise, significant issues around off-target effects, mosaicism, and ethical concerns must still be addressed before any clinical applications. The document concludes that further basic research is needed to advance the field while also having open discussions on societal implications.
Introduction to CRISPR Cas9 technology. View in slide show after downloading for better viewing. Description is minimal, but it will be worth going through the slides that are full of pictures, if you have a minimal understanding of CRISPR.
Prepared in Oct 2015
CRISPR/Cas9 system consists of a “guide” RNA (gRNA) and a bacterial CRISPR-associated endonuclease (Cas9). The gRNA is a short synthetic RNA composed of a Cas9-binding “scaffold” sequence and ∼20 nucleotide “targeting” sequence that defines the target genomic site to be modified.
https://www.creative-biogene.com/Services/Stable-cell-line-generation/Custom-Genome-Editing-Cell-Lines.html
CRISPR Cas9 is a genome editing technology that allows genetic material to be added, removed, or altered from a genome. It originated as a bacterial immune system but can now be directed to make precise edits to DNA. The technology has wide applications for gene therapy, agriculture, research, and more, but also raises ethical concerns if misused. CRISPR offers promising possibilities but also challenges that must be addressed regarding safety, accuracy, and societal effects.
CRISPR-Cas9 is a gene editing technology that uses the bacterial immune system to cut DNA at specific locations. It allows researchers to understand, characterize, and control DNA. CRISPR-Cas9 uses an RNA-guided DNA endonuclease enzyme called Cas9 that is directed by guide RNA to cleave target DNA. It has numerous applications including modifying genes in plants and animals, developing disease resistant crops, and potentially curing genetic diseases in humans by precisely editing genes. While revolutionary, it also raises ethical concerns that must be considered and addressed.
Crispr cas9 and applications of the technologyNEHA MAHATO
The most talked about gene editing tool- CRISPR Cas9 and its applications in all the possible spheres of science and research is talked about in brief in this presentation.
This document discusses gene editing applications using CRISPR-Cas9, including in gametes and embryos. It provides background on the development of CRISPR-Cas9 as a gene editing tool. Genome editing has been applied to male and female germ cells in animal models and research embryos to correct genetic mutations. However, human embryo genome editing faces limitations such as mosaicism and off-target effects. While genome editing holds promise for treating genetic diseases, more research is needed to improve specificity and fidelity before clinical applications.
The document summarizes key aspects of CRISPR genome editing technology. It describes how CRISPR uses Cas9 and guide RNA to precisely target and edit DNA sequences. It provides a brief history of CRISPR discovery and outlines its components and mechanism of action. The document also discusses several medical applications of CRISPR including treating Duchenne muscular dystrophy, beta-thalassemia, and testing for viruses. It concludes that CRISPR is a flexible and accurate gene editing tool being explored for various applications in agriculture, biotechnology, and medicine.
Genome Editing Techniques by Kainat RamzanKainatRamzan3
Genome technology has revolutionized biological science through techniques of Gene Editing in order to edit any organism's genome.MegNs and zinc-finger nucleases are commonly understood to be used, as is the effector's transcriptional activator-like nucleases. In CRISPR/Cas9, genetic alterations, and gene functionality have become a well-known tool for understanding gene targeting.
CRISPR is a bacterial adaptive immune system that provides immunity against viruses. It has been adapted for genome editing using Cas9 nuclease guided by a synthetic single guide RNA. The Cas9-guide RNA complex binds target DNA and makes a double-strand break, which can be repaired by non-homologous end joining to disrupt a gene or by homology-directed repair with a donor template to edit the genome. This powerful new technology allows various genome editing applications such as gene knockouts, insertions, corrections, and regulation of gene expression.
This document provides an overview of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology. It discusses how CRISPR is an adaptive immune system in bacteria that allows them to recognize and destroy phages. The CRISPR-Cas9 system in particular allows for genome engineering by using the Cas9 enzyme guided by CRISPR sequences to cleave specific DNA strands. The document then goes into more detail about the mechanisms of CRISPR in bacteria, including adaptation, expression and interference phases. It also discusses the different types of CRISPR systems and their characteristics.
This document provides an overview of the CRISPR-Cas immune system in bacteria and its applications. It discusses:
1. The history and components of the CRISPR-Cas system, including Cas proteins, CRISPR RNA, and protospacer adjacent motifs.
2. The three main types of CRISPR-Cas systems and their mechanisms of targeting DNA or RNA.
3. How engineered versions of Cas9 can be used for targeted genome editing and modulation of gene expression in mammalian cells.
4. Applications of CRISPR-Cas in microbiology such as genetic engineering of bacteria, gene repression/activation using deactivated Cas9, and developing sequence-specific antimicrobials.
The presentation discusses CRISPR/Cas9, a technology that uses a molecular scissor called Cas9 and guide RNA to selectively edit genome sequences. It can disable or change gene sequences and is used in gene therapy to treat cancer and inherited disorders. CRISPR/Cas9 works by creating double-strand breaks in DNA at targeted locations guided by the RNA, and the breaks can then be repaired through non-homologous end joining or homologous direct repair with or without introducing new genetic material. The technology provides a simple and effective way to edit genes and is useful for genetic therapeutics, medicine, and cell and molecular research.
CRISPR-CAS System: From Adaptive Immunity To Genome editingDebanjan Pandit
The document summarizes the CRISPR-Cas system, beginning with what CRISPR refers to as patterns of DNA sequences found in bacterial genomes. It describes the three stages of adaptive immunity in CRISPR-Cas systems: insertion of invading DNA as a spacer, transcription of precursor CRISPR RNA which is processed into individual CRISPR RNAs targeting the invader, and Cas protein-directed cleavage of foreign nucleic acid guided by the CRISPR RNA. Applications of CRISPR-Cas systems discussed include genome editing, gene regulation through catalytically inactive Cas9 fusion proteins, cargo delivery by fusing Cas9 to other proteins, and RNA cleavage by Type III CRISPR-Cas systems.
This document discusses the CRISPR-Cas9 system for genome editing and its applications. It provides a brief history of CRISPR's discovery and development as a tool. CRISPR-Cas9 uses CRISPR sequences and Cas9 nuclease to precisely target and edit DNA. The document outlines the basic components and mechanisms of CRISPR-Cas9, as well as its current applications in cancer immunotherapy, inhibiting angiogenesis, and correcting genetic disorders.
Genome editing uses engineered nucleases to insert, delete, or replace sections of the genome. CRISPR/Cas9 is a popular genome editing technique that uses guide RNA to direct nucleases to specific DNA sequences. While promising for treating disease, human germline editing raises ethical concerns. Early studies editing human embryos and non-viable embryos demonstrated proof-of-concept but had low efficiencies and off-target mutations. Later studies improved targeting and showed potential for correcting genetic defects. However, regulation is needed as the first claimed use of CRISPR to genetically edit human babies was unapproved.
It is very fast and new technique for detection and degradation of viral DNA and it is so helpful for us to understand how to degraded viral DNA... what type of function naturally present in bacteria........ so its very excellent technique
CRISPR-Cas systems provide bacteria with acquired immunity against viruses and plasmids. CRISPR loci contain repeating sequences separated by unique spacer sequences that are derived from invading genetic elements. Cas proteins process CRISPR RNA transcripts from the loci into small CRISPR RNAs that guide the degradation of invading nucleic acids based on sequence complementarity. This three-stage CRISPR-Cas immune response of adaptation, expression, and interference integrates new spacers and uses CRISPR RNAs to target matching foreign genetic elements. CRISPR-Cas systems are found in many bacteria and archaea and can be exploited for applications like bacterial typing, evolution studies, and generating phage resistance.
i explained about basics of genome engineering and crispr system.
CRISPR will change the world and it is just the beginning, are you ready to meet the future? you think its great and beautiful or.....?
please give your feedback to my email
pooyanaghshbandi@yahoo.com
i am starting to write a critical and fantastic review article about CRISPR, if you are interested to join please contact me.
The document provides an overview of the CRISPR/Cas9 gene editing technology. It discusses the history and components of the CRISPR system, how it works, applications in various fields like microbiology, biomedicine, agriculture, and therapeutics. Recent advances expand its use for transcriptional regulation, epigenetic editing, and live imaging. While powerful, it faces challenges like off-target effects that require further research to optimize its safe and ethical application.
CRISPR/Cas9 is a genome editing technique that allows for highly specific modification of DNA. It involves a Cas9 protein guiding a customized RNA to a target location in the genome to cut DNA. Scientists adapted the natural CRISPR immune system found in bacteria for genome editing. CRISPR/Cas9 holds promise for treating genetic diseases and developing crops but also raises ethical concerns when applied to human germline cells due to heritable effects. Researchers continue improving targeting specificity and developing new Cas proteins for additional applications in genome editing and gene regulation.
CRISPR/Cas9 system consists of a “guide” RNA (gRNA) and a bacterial CRISPR-associated endonuclease (Cas9). The gRNA is a short synthetic RNA composed of a Cas9-binding “scaffold” sequence and ∼20 nucleotide “targeting” sequence that defines the target genomic site to be modified.
https://www.creative-biogene.com/Services/Stable-cell-line-generation/Custom-Genome-Editing-Cell-Lines.html
CRISPR Cas9 is a genome editing technology that allows genetic material to be added, removed, or altered from a genome. It originated as a bacterial immune system but can now be directed to make precise edits to DNA. The technology has wide applications for gene therapy, agriculture, research, and more, but also raises ethical concerns if misused. CRISPR offers promising possibilities but also challenges that must be addressed regarding safety, accuracy, and societal effects.
CRISPR-Cas9 is a gene editing technology that uses the bacterial immune system to cut DNA at specific locations. It allows researchers to understand, characterize, and control DNA. CRISPR-Cas9 uses an RNA-guided DNA endonuclease enzyme called Cas9 that is directed by guide RNA to cleave target DNA. It has numerous applications including modifying genes in plants and animals, developing disease resistant crops, and potentially curing genetic diseases in humans by precisely editing genes. While revolutionary, it also raises ethical concerns that must be considered and addressed.
Crispr cas9 and applications of the technologyNEHA MAHATO
The most talked about gene editing tool- CRISPR Cas9 and its applications in all the possible spheres of science and research is talked about in brief in this presentation.
This document discusses gene editing applications using CRISPR-Cas9, including in gametes and embryos. It provides background on the development of CRISPR-Cas9 as a gene editing tool. Genome editing has been applied to male and female germ cells in animal models and research embryos to correct genetic mutations. However, human embryo genome editing faces limitations such as mosaicism and off-target effects. While genome editing holds promise for treating genetic diseases, more research is needed to improve specificity and fidelity before clinical applications.
The document summarizes key aspects of CRISPR genome editing technology. It describes how CRISPR uses Cas9 and guide RNA to precisely target and edit DNA sequences. It provides a brief history of CRISPR discovery and outlines its components and mechanism of action. The document also discusses several medical applications of CRISPR including treating Duchenne muscular dystrophy, beta-thalassemia, and testing for viruses. It concludes that CRISPR is a flexible and accurate gene editing tool being explored for various applications in agriculture, biotechnology, and medicine.
Genome Editing Techniques by Kainat RamzanKainatRamzan3
Genome technology has revolutionized biological science through techniques of Gene Editing in order to edit any organism's genome.MegNs and zinc-finger nucleases are commonly understood to be used, as is the effector's transcriptional activator-like nucleases. In CRISPR/Cas9, genetic alterations, and gene functionality have become a well-known tool for understanding gene targeting.
CRISPR is a bacterial adaptive immune system that provides immunity against viruses. It has been adapted for genome editing using Cas9 nuclease guided by a synthetic single guide RNA. The Cas9-guide RNA complex binds target DNA and makes a double-strand break, which can be repaired by non-homologous end joining to disrupt a gene or by homology-directed repair with a donor template to edit the genome. This powerful new technology allows various genome editing applications such as gene knockouts, insertions, corrections, and regulation of gene expression.
This document provides an overview of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology. It discusses how CRISPR is an adaptive immune system in bacteria that allows them to recognize and destroy phages. The CRISPR-Cas9 system in particular allows for genome engineering by using the Cas9 enzyme guided by CRISPR sequences to cleave specific DNA strands. The document then goes into more detail about the mechanisms of CRISPR in bacteria, including adaptation, expression and interference phases. It also discusses the different types of CRISPR systems and their characteristics.
This document provides an overview of the CRISPR-Cas immune system in bacteria and its applications. It discusses:
1. The history and components of the CRISPR-Cas system, including Cas proteins, CRISPR RNA, and protospacer adjacent motifs.
2. The three main types of CRISPR-Cas systems and their mechanisms of targeting DNA or RNA.
3. How engineered versions of Cas9 can be used for targeted genome editing and modulation of gene expression in mammalian cells.
4. Applications of CRISPR-Cas in microbiology such as genetic engineering of bacteria, gene repression/activation using deactivated Cas9, and developing sequence-specific antimicrobials.
The presentation discusses CRISPR/Cas9, a technology that uses a molecular scissor called Cas9 and guide RNA to selectively edit genome sequences. It can disable or change gene sequences and is used in gene therapy to treat cancer and inherited disorders. CRISPR/Cas9 works by creating double-strand breaks in DNA at targeted locations guided by the RNA, and the breaks can then be repaired through non-homologous end joining or homologous direct repair with or without introducing new genetic material. The technology provides a simple and effective way to edit genes and is useful for genetic therapeutics, medicine, and cell and molecular research.
CRISPR-CAS System: From Adaptive Immunity To Genome editingDebanjan Pandit
The document summarizes the CRISPR-Cas system, beginning with what CRISPR refers to as patterns of DNA sequences found in bacterial genomes. It describes the three stages of adaptive immunity in CRISPR-Cas systems: insertion of invading DNA as a spacer, transcription of precursor CRISPR RNA which is processed into individual CRISPR RNAs targeting the invader, and Cas protein-directed cleavage of foreign nucleic acid guided by the CRISPR RNA. Applications of CRISPR-Cas systems discussed include genome editing, gene regulation through catalytically inactive Cas9 fusion proteins, cargo delivery by fusing Cas9 to other proteins, and RNA cleavage by Type III CRISPR-Cas systems.
This document discusses the CRISPR-Cas9 system for genome editing and its applications. It provides a brief history of CRISPR's discovery and development as a tool. CRISPR-Cas9 uses CRISPR sequences and Cas9 nuclease to precisely target and edit DNA. The document outlines the basic components and mechanisms of CRISPR-Cas9, as well as its current applications in cancer immunotherapy, inhibiting angiogenesis, and correcting genetic disorders.
Genome editing uses engineered nucleases to insert, delete, or replace sections of the genome. CRISPR/Cas9 is a popular genome editing technique that uses guide RNA to direct nucleases to specific DNA sequences. While promising for treating disease, human germline editing raises ethical concerns. Early studies editing human embryos and non-viable embryos demonstrated proof-of-concept but had low efficiencies and off-target mutations. Later studies improved targeting and showed potential for correcting genetic defects. However, regulation is needed as the first claimed use of CRISPR to genetically edit human babies was unapproved.
It is very fast and new technique for detection and degradation of viral DNA and it is so helpful for us to understand how to degraded viral DNA... what type of function naturally present in bacteria........ so its very excellent technique
CRISPR-Cas systems provide bacteria with acquired immunity against viruses and plasmids. CRISPR loci contain repeating sequences separated by unique spacer sequences that are derived from invading genetic elements. Cas proteins process CRISPR RNA transcripts from the loci into small CRISPR RNAs that guide the degradation of invading nucleic acids based on sequence complementarity. This three-stage CRISPR-Cas immune response of adaptation, expression, and interference integrates new spacers and uses CRISPR RNAs to target matching foreign genetic elements. CRISPR-Cas systems are found in many bacteria and archaea and can be exploited for applications like bacterial typing, evolution studies, and generating phage resistance.
i explained about basics of genome engineering and crispr system.
CRISPR will change the world and it is just the beginning, are you ready to meet the future? you think its great and beautiful or.....?
please give your feedback to my email
pooyanaghshbandi@yahoo.com
i am starting to write a critical and fantastic review article about CRISPR, if you are interested to join please contact me.
The document provides an overview of the CRISPR/Cas9 gene editing technology. It discusses the history and components of the CRISPR system, how it works, applications in various fields like microbiology, biomedicine, agriculture, and therapeutics. Recent advances expand its use for transcriptional regulation, epigenetic editing, and live imaging. While powerful, it faces challenges like off-target effects that require further research to optimize its safe and ethical application.
CRISPR/Cas9 is a genome editing technique that allows for highly specific modification of DNA. It involves a Cas9 protein guiding a customized RNA to a target location in the genome to cut DNA. Scientists adapted the natural CRISPR immune system found in bacteria for genome editing. CRISPR/Cas9 holds promise for treating genetic diseases and developing crops but also raises ethical concerns when applied to human germline cells due to heritable effects. Researchers continue improving targeting specificity and developing new Cas proteins for additional applications in genome editing and gene regulation.
This document provides an overview of CRISPR-Cas9 gene editing technology and its applications in food editing. It explains that CRISPR-Cas9 utilizes guide RNA and Cas9 nuclease to precisely target and edit DNA sequences. The document discusses how CRISPR-Cas9 is being used to improve crop traits like yield, nutrition, and disease resistance in tomatoes, rice, wheat, and other plants. While promising for agriculture, the document notes there are still controversies around off-target effects and safety that require further study before wide application of CRISPR gene editing in food.
This document summarizes information about the CRISPR Cas9 genome editing tool. It discusses how CRISPR Cas9 uses guide RNA and the Cas9 enzyme to create targeted double-strand breaks in DNA, allowing genes to be knocked out or altered. The document outlines the history and mechanism of CRISPR Cas9, compares it to other genome editing tools, discusses its applications in plant breeding including reducing off-target effects, and provides an example of using it to create parthenocarpic tomato plants.
CRISPR/Cas9 is a powerful genome editing tool that allows genetic material to be added, altered or removed at specific locations in the genome. It involves a bacterial adaptive immune system where CRISPR sequences and Cas genes work together. The Cas9 protein uses a guide RNA to introduce double stranded breaks at targeted DNA sequences. This enables precise genome editing through non-homologous end joining or homology directed repair. CRISPR/Cas9 provides a simple and accurate way to modify genes for applications in research, medicine, agriculture and more. While it holds great promise, there are also limitations and concerns regarding off-target effects that researchers continue working to address.
CRISPR/Cas9 is an advanced genome editing technology that can be used to develop plant disease resistance. It involves a Cas9 enzyme that acts like molecular scissors to cut DNA at specific locations guided by CRISPR RNA. This triggers DNA repair that can introduce changes to genes. Researchers have used CRISPR/Cas9 to develop resistance in plants against viruses, fungi, and bacteria by editing genes involved in host-pathogen interaction and disease susceptibility. It provides a precise and efficient way to edit plant genomes to improve crop resistance compared to previous tools. Scientists continue working to enhance the specificity and control of CRISPR/Cas9 for genome editing applications in agriculture.
Application of crispr in cancer therapykamran javidi
Many bacterial clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated (Cas) systems employ the dual RNA–guided DNA endonuclease Cas9 to defend against invading phages and conjugative plasmids by introducing site-specific double-stranded breaks in target DNA. Target recognition strictly requires the presence of a short protospacer adjacent motif (PAM) flanking the target site, and subsequent R-loop formation and strand scission are driven by complementary base pairing between the guide RNA and target DNA, Cas9–DNA interactions, and associated conformational changes. The use of CRISPR–Cas9 as an RNA-programmable
DNA targeting and editing platform is simplified by a synthetic single-guide RNA (sgRNA) mimicking the natural dual trans-activating CRISPR RNA (tracrRNA)–CRISPR RNA (crRNA) structure
CRISPR-Cas9 is a gene editing technique that utilizes the Cas9 enzyme to cut DNA at specific locations guided by CRISPR RNA. It allows scientists to precisely modify genes and has applications in medicine, agriculture, and scientific research. Some examples include developing disease-resistant crops and mosquitoes, growing human organs in pigs, and potentially curing genetic diseases. While promising, CRISPR also faces ethical concerns regarding safety, unintended effects, germline editing, and unequal access to treatment. Overall, CRISPR is a revolutionary new biotechnology but more research is still needed to fully realize its benefits and address ethical implications.
CRISPR/Cas9 gene editing is based on a microbial restriction system, that has been harnessed for genome targeting using only a short sequence of RNA as a guide.
The beauty of the system is that unlike protein binding based technologies such as Zinc Fingers and TALENs which require complex protein engineering, the design rules are very simple, and it is this fact that is allowing CRISPR to take genome engineering from a relatively niche persuit to the mainstream scientific community.
The principle of the system is that a short guide RNA, homologous to the target site recruits a nuclease – Cas9
This then cuts the dsDNA, triggering repair by either the low fidelity NHEJ pathway, or by HDR in the presence of an exogenous donor sequence.
High Efficiencies for both knockouts and knock-ins have been reported and whilst there are understandable concerns about specificity, new methodologies to address these are now being developed
The system itself is comprised of three key components
the Cas9 protein, which cuts/cleaves the DNA and
Two RNAs - a crispr RNA contains the sequence homologous to the target site and a trans-activating crisprRNA (or TracrRNA) which recruits the nuclease/crispr complex
For genome editing, the crisperRNA and TraceRNA are generally now constructed together into a single guideRNA or sgRNA
Genome editing is elicited through hybridization of the sgRNA with its matching genomic sequence, and the recruitment of the Cas9, which cleaves at the target site.
CRISPR/Cas9 gene editing is based on a microbial restriction system, that has been harnessed for genome targeting using only a short sequence of RNA as a guide.
CRISPR-Cas9 is a gene editing technology that uses the Cas9 enzyme guided by CRISPR sequences to target and cleave specific strands of DNA. It provides a simple and precise way to edit genes and is being applied in agriculture, animal breeding, and biomedicine. In agriculture, CRISPR-Cas9 is being used to develop virus-resistant and disease-resistant crops with improved traits like increased nutritional content and stress tolerance. In animals, it is modifying traits like disease resistance and removing allergens from products like eggs and milk. Future applications include improving human health by editing disease-causing genes and enabling organ transplantation.
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)Akshay Deshmukh
clustered regularly interspaced short palindromic repeats is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria. Now CRISPR use as genome editing tool in different Plant Breeder to manipulate the DNA of the crop
This document discusses genome editing using the CRISPR-Cas9 system. It begins by introducing three main genome editing technologies - zinc-finger nucleases, TALENs, and the CRISPR-Cas9 system. It then describes the key events in the discovery of CRISPR-Cas9, including its origins as a bacterial defense system. The document outlines the main components of the CRISPR-Cas9 system, including crRNA, tracrRNA, sgRNA, and Cas9. It also summarizes the two main steps in genome editing using CRISPR-Cas9 - knocking out genes and DNA repair. The document concludes by discussing opportunities for applying CRISPR-Cas9 technology across various
The Genome editing Era (CRISPER Cas 9) : State of the Art and Perspectives fo...Anand Choudhary
Role of CRISPR/Cas9 in plant pathology
Production of disease resistance cultivars by editing the genome which is responsible for susceptibility factor for fungal and bacterial diseases.
By editing the genome which governs host pathogen interaction we can obtain incompatible interaction between host pathogen.
To improve the efficacy of bio control agents.
By editing the genome responsible for virus multiplication and virulence we can obtain virus free resistance cultivars.
The Genome-editing Era (CRISPER Cas 9) : State of the Art and Perspectives fo...ANAND CHOUDHARY
Role of CRISPR/Cas9 in plant pathology
Production of disease resistance cultivars by editing the genome which is responsible for susceptibility factor for fungal and bacterial diseases.
By editing the genome which governs host pathogen interaction we can obtain incompatible interaction between host pathogen.
To improve the efficacy of bio control agents.
By editing the genome responsible for virus multiplication and virulence we can obtain virus free resistance cultivars.
Genome editing tool Crispr Cas 9 in modifying Plant GenomeHrithikPandey9
CRISPR acronym, Clustered Regularly Interspaced Palindromic Repeats
The CRISPR–Cas system is an adaptive immune system in prokaryotes that prevents phage infection by storing memory in the form of viral DNA in bacterial host chromosomes.
CRISPR is a new mechanism\tool to edit genes and in coming future it will provide us many new levels of success in curing of genetic disorders and modifying genes for human benifit
This document provides an overview of CRISPR/Cas9 gene editing technology. It discusses the history of CRISPR discoveries from 1993 onwards and how the technology has been adapted for genome editing. Previous gene editing methods like ZFNs, TALENs and rAAVs are also summarized. The document then explains in detail how the CRISPR/Cas9 system works to edit genomes using a Cas9 enzyme guided by CRISPR RNA. Applications of CRISPR like genomic editing through knockouts and gene silencing are highlighted.
The document discusses the CRISPR-Cas9 genome editing tool. CRISPR-Cas9 uses an enzyme called Cas9 and a guide RNA to cut DNA at a specific location, allowing DNA to be removed, added, or altered. It was developed based on the bacterial immune system and provides a simple, precise way to edit genomes. While promising for treating genetic diseases, its use in germline editing raises ethical concerns that require further discussion.
Discovery of An Apparent Red, High-Velocity Type Ia Supernova at 𝐳 = 2.9 wi...Sérgio Sacani
We present the JWST discovery of SN 2023adsy, a transient object located in a host galaxy JADES-GS
+
53.13485
−
27.82088
with a host spectroscopic redshift of
2.903
±
0.007
. The transient was identified in deep James Webb Space Telescope (JWST)/NIRCam imaging from the JWST Advanced Deep Extragalactic Survey (JADES) program. Photometric and spectroscopic followup with NIRCam and NIRSpec, respectively, confirm the redshift and yield UV-NIR light-curve, NIR color, and spectroscopic information all consistent with a Type Ia classification. Despite its classification as a likely SN Ia, SN 2023adsy is both fairly red (
�
(
�
−
�
)
∼
0.9
) despite a host galaxy with low-extinction and has a high Ca II velocity (
19
,
000
±
2
,
000
km/s) compared to the general population of SNe Ia. While these characteristics are consistent with some Ca-rich SNe Ia, particularly SN 2016hnk, SN 2023adsy is intrinsically brighter than the low-
�
Ca-rich population. Although such an object is too red for any low-
�
cosmological sample, we apply a fiducial standardization approach to SN 2023adsy and find that the SN 2023adsy luminosity distance measurement is in excellent agreement (
≲
1
�
) with
Λ
CDM. Therefore unlike low-
�
Ca-rich SNe Ia, SN 2023adsy is standardizable and gives no indication that SN Ia standardized luminosities change significantly with redshift. A larger sample of distant SNe Ia is required to determine if SN Ia population characteristics at high-
�
truly diverge from their low-
�
counterparts, and to confirm that standardized luminosities nevertheless remain constant with redshift.
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDSSérgio Sacani
The pathway(s) to seeding the massive black holes (MBHs) that exist at the heart of galaxies in the present and distant Universe remains an unsolved problem. Here we categorise, describe and quantitatively discuss the formation pathways of both light and heavy seeds. We emphasise that the most recent computational models suggest that rather than a bimodal-like mass spectrum between light and heavy seeds with light at one end and heavy at the other that instead a continuum exists. Light seeds being more ubiquitous and the heavier seeds becoming less and less abundant due the rarer environmental conditions required for their formation. We therefore examine the different mechanisms that give rise to different seed mass spectrums. We show how and why the mechanisms that produce the heaviest seeds are also among the rarest events in the Universe and are hence extremely unlikely to be the seeds for the vast majority of the MBH population. We quantify, within the limits of the current large uncertainties in the seeding processes, the expected number densities of the seed mass spectrum. We argue that light seeds must be at least 103 to 105 times more numerous than heavy seeds to explain the MBH population as a whole. Based on our current understanding of the seed population this makes heavy seeds (Mseed > 103 M⊙) a significantly more likely pathway given that heavy seeds have an abundance pattern than is close to and likely in excess of 10−4 compared to light seeds. Finally, we examine the current state-of-the-art in numerical calculations and recent observations and plot a path forward for near-future advances in both domains.
Microbial interaction
Microorganisms interacts with each other and can be physically associated with another organisms in a variety of ways.
One organism can be located on the surface of another organism as an ectobiont or located within another organism as endobiont.
Microbial interaction may be positive such as mutualism, proto-cooperation, commensalism or may be negative such as parasitism, predation or competition
Types of microbial interaction
Positive interaction: mutualism, proto-cooperation, commensalism
Negative interaction: Ammensalism (antagonism), parasitism, predation, competition
I. Mutualism:
It is defined as the relationship in which each organism in interaction gets benefits from association. It is an obligatory relationship in which mutualist and host are metabolically dependent on each other.
Mutualistic relationship is very specific where one member of association cannot be replaced by another species.
Mutualism require close physical contact between interacting organisms.
Relationship of mutualism allows organisms to exist in habitat that could not occupied by either species alone.
Mutualistic relationship between organisms allows them to act as a single organism.
Examples of mutualism:
i. Lichens:
Lichens are excellent example of mutualism.
They are the association of specific fungi and certain genus of algae. In lichen, fungal partner is called mycobiont and algal partner is called
II. Syntrophism:
It is an association in which the growth of one organism either depends on or improved by the substrate provided by another organism.
In syntrophism both organism in association gets benefits.
Compound A
Utilized by population 1
Compound B
Utilized by population 2
Compound C
utilized by both Population 1+2
Products
In this theoretical example of syntrophism, population 1 is able to utilize and metabolize compound A, forming compound B but cannot metabolize beyond compound B without co-operation of population 2. Population 2is unable to utilize compound A but it can metabolize compound B forming compound C. Then both population 1 and 2 are able to carry out metabolic reaction which leads to formation of end product that neither population could produce alone.
Examples of syntrophism:
i. Methanogenic ecosystem in sludge digester
Methane produced by methanogenic bacteria depends upon interspecies hydrogen transfer by other fermentative bacteria.
Anaerobic fermentative bacteria generate CO2 and H2 utilizing carbohydrates which is then utilized by methanogenic bacteria (Methanobacter) to produce methane.
ii. Lactobacillus arobinosus and Enterococcus faecalis:
In the minimal media, Lactobacillus arobinosus and Enterococcus faecalis are able to grow together but not alone.
The synergistic relationship between E. faecalis and L. arobinosus occurs in which E. faecalis require folic acid
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptxshubhijain836
Centrifugation is a powerful technique used in laboratories to separate components of a heterogeneous mixture based on their density. This process utilizes centrifugal force to rapidly spin samples, causing denser particles to migrate outward more quickly than lighter ones. As a result, distinct layers form within the sample tube, allowing for easy isolation and purification of target substances.
Signatures of wave erosion in Titan’s coastsSérgio Sacani
The shorelines of Titan’s hydrocarbon seas trace flooded erosional landforms such as river valleys; however, it isunclear whether coastal erosion has subsequently altered these shorelines. Spacecraft observations and theo-retical models suggest that wind may cause waves to form on Titan’s seas, potentially driving coastal erosion,but the observational evidence of waves is indirect, and the processes affecting shoreline evolution on Titanremain unknown. No widely accepted framework exists for using shoreline morphology to quantitatively dis-cern coastal erosion mechanisms, even on Earth, where the dominant mechanisms are known. We combinelandscape evolution models with measurements of shoreline shape on Earth to characterize how differentcoastal erosion mechanisms affect shoreline morphology. Applying this framework to Titan, we find that theshorelines of Titan’s seas are most consistent with flooded landscapes that subsequently have been eroded bywaves, rather than a uniform erosional process or no coastal erosion, particularly if wave growth saturates atfetch lengths of tens of kilometers.
This presentation offers a general idea of the structure of seed, seed production, management of seeds and its allied technologies. It also offers the concept of gene erosion and the practices used to control it. Nursery and gardening have been widely explored along with their importance in the related domain.
The cost of acquiring information by natural selectionCarl Bergstrom
This is a short talk that I gave at the Banff International Research Station workshop on Modeling and Theory in Population Biology. The idea is to try to understand how the burden of natural selection relates to the amount of information that selection puts into the genome.
It's based on the first part of this research paper:
The cost of information acquisition by natural selection
Ryan Seamus McGee, Olivia Kosterlitz, Artem Kaznatcheev, Benjamin Kerr, Carl T. Bergstrom
bioRxiv 2022.07.02.498577; doi: https://doi.org/10.1101/2022.07.02.498577
5. Exogenous DNA is processed by Cas proteins into short (20-30 base
pairs) sequences that are adjacent to the Protospacer Adjacent Motif
(PAM) site.
These short pieces of DNA are then incorporated into the host
genome between CRISPR repeats, and serve as a 'memory' of past
exposures.
9. HERE, THE RNA IS A GUIDE TO FIND
MORE MATCHING DNA CHUNKS
CAS9 IS ANOTHER ONE OF THOSE
NUCLEASE PROTEINS, AND
IT CUTS WHEREVER THE GUIDE RNA
TELLS IT TO
11. MANY APPLICATIONS IN ANIMALS
AND PLANTS
ACCURATE DNA TARGETING
MECHANISM
SOFTWARE VS HARDWARE
MAKING A SPECIFIC
SEQUENCE OF RNA IS MUCH
EASIER THAN MAKING A
SPECIFIC 3D PROTEIN
13. Gene editing in preimplantation embryos
The editing system is directly microinjected into the cytoplasm or
pronuclei of zygotes.
Affected sperm
Affected oocyte
IVF/ICSI
CRISPR/Cas9
editing in embryo
Corrected embryo
Corrected embryoCRISPR/Cas9
editing in embryo
IVF/ICSI
14. Let’s take an example..
Xiangjin Kang in 2015, introduced the naturally occurring
CCR5Δ32 allele into early human tripronuclear (3PN)
embryos by CRISPR/Cas9 mediated genome editing.
15. Gene editing of male germ cells
Testis biopsy Spermatogonia SC
derivation
CRISPR/Cas9 editing
in spermatogonia SC
Gamete differentiation
Corrected sperm ICSI
Gene modification could be applied during
gametogenesis.
The CRISPR/Cas9 system could be used on
sperm to generate gene corrected mature
sperm.
16. Gene editing of female germ cells
GV oocyte CRISPR/Cas9 editing
in oocytes
In vitro maturation
Corrected
oocyte
ICSI
The CRISPR/Cas9 system could be used on
growing immature oocytes to generate gene
corrected mature oocytes.
17. Pluripotent cells editing and differentiation
Induced Pluripotent Stem cells—iPSC
Can be grown easily in bulk amounts
Sustain single cell passaging
Skin biopsy
Reprogramming
iPS derivation
CRISPR/Cas9 editing
In iPS
Gamete differentiation
ICSI
18. The main concerns are …
Mosaicism embryos
Inefficient nuclease cutting
Inaccurate DNA repair
off-targets mutations
Heritable off-target mutations
19. Possible uses of genome editing in repr
• Germ line modifications for genetic disease correction
• Correction of non-medical conditions
20. Germ line modifications for genetic disease
correction
Autosomal recessive diseases
Two carrier/one affected parents PGD
Both parents are affected CRISPR/Cas9 for one of
the parents
healthy carriers
21. Autosomal dominant disease
Allows the patients to produce sperm or
oocytes that are free from the mutation.
Germ line modifications for genetic disease
correction
Chromosomal aberrations
The Robertsonian translocation 21;21
25. References:
Doudna, Jennifer A., and Emmanuelle Charpentier. "The new frontier of
genome engineering with CRISPR-Cas9." Science 346.6213 (2014): 1258096.
Harrison, Melissa M., et al. "A CRISPR view of development." Genes &
development 28.17 (2014): 1859-1872.
Kang, Xiangjin, et al. "Introducing precise genetic modifications into human
3PN embryos by CRISPR/Cas-mediated genome editing." Journal of assisted
reproduction and genetics 33.5 (2016): 581-588.
Smertenko, Andrei, and Peter V. Bozhkov. "Somatic embryogenesis: life and
death processes during apical–basal patterning." Journal of experimental
botany (2014): eru005.
Vassena, R., et al. "Genome engineering through CRISPR/Cas9 technology in
the human germline and pluripotent stem cells." Human reproduction update
(2016): dmw005.
Editor's Notes
Animated slide!
Animated slide!
… AND JUST SIT THERE.
Animated slide!
- Ethical issues
- Some limitations
before CRISPR/Cas9 technology could be translated to the clinic, some problems will need to be resolved; the main issue is mosaicism, together with off-target effects and unwanted random genome integration of oligonucleotides and constructs.